Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection (Q36168439)

12 August 2017

Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection (English)

1 reference

12 August 2017

0 references

0 references

1 reference

1 reference

Michael Willis

0 references

Christian Asseburg

0 references

Niko Seppälä

1 reference

12 August 2017

Mickael Löthgren

1 reference

12 August 2017

Mika Hakala

series ordinal

1 reference

12 August 2017

Ulf Persson

series ordinal

1 reference

12 August 2017

7 May 2012

1 reference

Schizophrenia Research and Treatment

12 August 2017

1 reference

12 August 2017

2012

1 reference

12 August 2017

791468

1 reference

Creative Commons Attribution 3.0 Unported

12 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

The impact on schizophrenia-related hospital utilization and costs of switching to long-acting risperidone injections in Sweden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3420409

Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3420409

Impact of risperidone long acting injection on resource utilization in psychiatric secondary care.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3420409

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3420409

Unanswered questions in schizophrenia clinical trials

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3420409

Thirty-five months experience of risperidone long-acting injection in a UK psychiatric service including a mirror-image analysis of in-patient care

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3420409

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3420409

Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3420409

Methods for claims-based pharmacoeconomic studies in psychosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3420409

Common errors and controversies in pharmacoeconomic analyses

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3420409

Pharmacoeconomic evaluation of antipsychotic therapy for schizophrenia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3420409

Relapse and long-acting injectable risperidone: a 1-year mirror image study with a national claims database in Taiwan

2 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F791468

Comparative effectiveness of long-acting risperidone in New Zealand: a report of resource utilization and costs in a 12-month mirror-image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F791468

Regression to the mean: treatment effect without the intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F791468

Selection Bias in Clinical Trials With Antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F791468

Switching antipsychotics. Antipsychotic tolerance, withdrawal and relapse: unresolved issues and research implications

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22966445

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2012/791468

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22966445

1 reference